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SUMMARY
Proper control of the mitochondrial Ca2+ uniporter’s pore (MCU) is required to allow Ca2+ 
dependent activation of oxidative metabolism and to avoid mitochondrial Ca2+ overload and cell 
death. The MCU’s gatekeeping and cooperative activation is mediated by the Ca2+ sensing 
MICU1 protein, which has been proposed to form dimeric complexes anchored to the EMRE 
scaffold of MCU. We unexpectedly find that MICU1 suppresses inhibition of MCU by ruthenium 
red/Ru360, which bind to MCU’s DIME motif, the selectivity filter. This led us to recognize in 
MICU1’s sequence, a putative DIME Interacting Domain (DID) which is required for both 
gatekeeping and cooperative activation of MCU and for cell survival. Thus, we propose that 
MICU1 has to interact with the D-ring formed by the DIME domains in MCU to control the 
uniporter.
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eTOC blurb
Paillard et al. report that mitochondrial Ca2+ uptake 1 (MICU1) interacts with the D-ring of MCU, 
the pore forming protein of the mitochondrial Ca2+ uniporter, through a DIME-interacting domain 
involving the arginines 440 and 443, to control both the Ca2+ flux and the Ruthenium Red 
sensitivity of the MCU complex.
Keywords
mitochondria; Ca2+ uptake; threshold; cooperativity; calcium signaling; oxidative stress
INTRODUCTION
The mitochondrial Ca2+ uniporter (mtCU) or MCU complex needs to be tightly regulated to 
avoid cell death by Ca2+ overload and to allow the Ca2+ dependent physiological stimulation 
of oxidative metabolism. Among the different components of the MCU complex, the Ca2+-
sensing protein MICU1 has been characterized as a key mediator of gatekeeping and 
cooperative activation of MCU, the pore-forming unit of the MCU complex (Csordas et al., 
2013; Kamer and Mootha, 2014; Mallilankaraman et al., 2012; Patron et al., 2014). MICU1 
has been linked to human neurological and muscular diseases (Lewis-Smith et al., 2016; 
Logan et al., 2014), as well as to liver regeneration (Antony et al., 2016), cardiac ischemia-
reperfusion injury (Xue et al., 2017), diabetic cardiomyopathy (Ji et al., 2017) and ovarian 
cancer (Chakraborty et al., 2017).
In addition to MCU and MICU1, other MCU complex components have also been 
identified: two paralogs of MICU1, MICU2 and MICU3 (Plovanich et al., 2013), a dominant 
negative paralog of MCU, MCUb (Raffaello et al., 2013), and the indispensable 
transmembrane protein EMRE (Sancak et al., 2013). MICU1 interacts with MICU2 through 
a disulfide bond involving C465 in MICU1 and C410 in MICU2, to form homo/
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heterodimers which control the MCU complex activity (Patron et al., 2014; Petrungaro et al., 
2015). On the other hand, MICU1 binding to the polyaspartate tail of EMRE has been 
shown to anchor MICU1 to the MCU complex in the mitochondrial intermembrane space 
and thus confer gatekeeping of the pore (Tsai et al., 2016). However, in the same study, 
MICU1’s interaction with MCU without EMRE was also shown by coimmunoprecipitation 
(Tsai et al., 2016), which is also supported by surface plasmon resonance data (Vecellio 
Reane et al., 2016).
Topology studies showed that most of MCU’s amino acid residues are in the two 
transmembrane domains and the N-and C-termini that are exposed to the mitochondrial 
matrix, and identified a short sequence between the two transmembrane domains, which is 
exposed to the intermembrane space (IMS) and might be accessible for direct interaction 
with IMS proteins like MICU1. This motif was termed as DIME (or DXXE) based on its 
amino acid sequence conserved across species (D261 and E264 in hsMCU) (Baughman et 
al., 2011). A recent study characterized the DIME domain as the ion selectivity filter of the 
MCU with ion binding to the two carboxylate rings (Cao et al., 2017). Notably, mutation of 
DIME domain also impaired the MICU1-MCU interaction (Patron et al., 2014). 
Interestingly, the inhibitory effect of the most potent inhibitors of the MCU complex, 
ruthenium red (RuRed) and ruthenium 360 (Ru360), requires S259 (Baughman et al., 2011). 
Two recent NMR studies further indicated that Ru360/RuRed binds the D-ring of MCU’s 
selectivity filter, which is solvent-exposed compared to the E-ring located deeper in the pore 
(Arduino et al., 2017; Cao et al., 2017). Thus, we reasoned that MICU1 might affect the 
RuRed sensitivity of the MCU complex through a potential interaction with the DIME 
domain of MCU.
We here, find that MICU1 deletion increases the MCU complex sensitivity to RuRed/Ru360, 
suggesting that MICU1 interferes with the binding site of these inhibitors in the DIME motif 
of MCU. We then identify a complementing sequence in MICU1 to the DIME motif, which 
we refer to as DIME interacting domain (DID) and predict that two arginines (R440 and 
R443) engage in potential salt bridges with the D-ring of MCU. Using an imaging approach 
to assess both threshold and cooperativity of the MCU complex in MICU1-KO mouse 
embryonic fibroblasts (MEFs) and HEK293 cells (HEKs), we show that the DID in MICU1 
is required to control the MCU complex-mediated Ca2+ influx and in turn, cell survival. 
Finally, we show that the DID of MICU1 alters the RuRed/Ru360 sensitivity by competing 
for the interaction with the DIME domain of MCU, thus opening a new avenue for 
therapeutic targeting of the MCU complex.
RESULTS
MICU1 controls the RuRed/Ru360 sensitivity of the MCU complex
While recording mitochondrial clearance of Ca2+ added to the cytoplasmic buffer of 
permeabilized hepatocytes isolated from wild type (Ctrl) and hepatocyte-specific MICU1−/− 
mouse (MICU1-KD), we noticed that deletion of MICU1 caused sensitization to RuRed, 
(Figures 1A and 1B). Specifically, MICU1-deficient mitochondria showed less effective 
uptake when a large Ca2+ bolus was applied (50μM CaCl2) as we reported earlier (Antony et 
al., 2016) and it was almost completely suppressed by a submaximal dose of RuRed 
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(100nM), which caused only a small inhibition in wild type (WT) mitochondria. When dose 
response curves were compiled, almost an order of magnitude increase in sensitivity for 
RuRed was observed in MICU1-deficient hepatocytes (Figure 1C). Higher sensitivity to 
RuRed was also observed in MICU1-deficient hepatocytes in response to a smaller bolus of 
Ca2+ (7µM; raising [Ca2+]c to 1.5-2 µM) (Figure S1), for which the mitochondrial Ca2+ 
uptake is similar to the control (Antony et al., 2016). The sensitivity was also increased 
towards Ru360 that is a more specific inhibitor of MCU complex (Figure 1D). Furthermore, 
sensitization to RuRed by MICU1 deletion was also found in MEFs (Figure 1E) and in 
HEKs (Figure 1F). Thus, these results provide evidence that MICU1 decreases the RuRed/
Ru360 sensitivity of the MCU complex, probably by competing with RuRed/Ru360 for 
binding to MCU.
MICU1 has a complementing sequence to the region of MCU determining RuRed 
sensitivity and Ca2+ selectivity
RuRed/Ru360 was recently shown to bind the DIME domain of MCU (Arduino et al., 2017; 
Baughman et al., 2011; Cao et al., 2017). The results shown in Figure 1 led us to postulate 
that there might be a domain in MICU1 which interacts with the DIME domain of MCU. It 
has been previously suggested that MICU1 interacts indirectly with MCU through EMRE, 
involving the transmembrane domains of MCU and EMRE, and EMRE binding to MICU1 
via EMRE’s C-terminal polyaspartate tail (Sancak et al., 2013; Tsai et al., 2016). 
Nevertheless, two studies using different techniques have indicated that MICU1 can interact 
with MCU without EMRE (Tsai et al., 2016; Vecellio Reane et al., 2016), supporting the 
possibility of an additional protein-protein interaction component. Moreover, along with the 
DIME domain of MCU (Patron et al., 2014), the C-terminal structure of MICU1 has been 
shown to be necessary for co-immunoprecipitation with MCU (Kamer and Mootha, 2014; 
Wang et al., 2014). However, the exact sequence in MICU1 involved in the binding to MCU 
is still unknown. Alignment of MICU1, 2 and 3 revealed a potential DIME interacting 
domain in the C-terminal sequence of all three MICUs, involving lysine K438 and two 
arginines R440 and R443 which could form potential salt bridges with the DIME domain in 
MCU (Figure 2A). Among the marked potential interactions, the one between K438 and the 
corresponding serine is more likely a dipole-dipole interaction than actual salt bridge 
between the positively charged amino group of lysine and the OH of serine. The crystal 
structure of MICU1 shows that the two arginine residues are orientated in the same direction 
in a helix (Wang et al., 2014), thus suggesting that the side-chains of R440 and R443 could 
act like RuRed to bind to the outer D-ring of the pore of the MCU pentamer (Cao et al., 
2017). To validate our hypothesis, we mutated in hsMICU1 these 3 residues to alanine 
(MICU1-∆DID: 440KQRLMR445>440AQALMA445) and analyzed its binding with MCU. 
MICU1-∆DID (tagged with HA) was pulled-down 60% less than WT MICU1 by MCU 
(tagged with FLAG) and, MCU was pulled-down in a lesser extent by MICU1-∆DID than 
WT MICU1 (Figure 2B). These results suggest that the KQRLMR sequence in MICU1, 
which we now named as DID (DIME Interaction Domain), interacts with MCU, probably 
through its DIME motif.
Next, using MICU1-KO MEFs, in which MICU2 is maintained (Antony et al., 2016), we 
aimed at better characterizing the functional role of the DID in MICU1 in the control of the 
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MCU complex Ca2+ flux. To assess MCU complex activity in individual cells, [Ca2+]m was 
followed via loading the mitochondria in WT and MICU1-KO MEF cells with the 
ratiometric probe furaFF/AM; cells were then permeabilized and subjected to a 2-step Ca2+ 
addition protocol (3 and 20µM CaCl2, 3 and 20Ca). Mitochondrial localization of the probe 
was confirmed by complete inhibition of the Ca2+ response by RuRed (Figure S2) (Paillard 
et al., 2017). As expected, MICU1-KO MEFs displayed an increased resting [Ca2+]m, which 
could be prevented by RuRed (Figure S2). The resting [Ca2+]m was used then as a measure 
of gatekeeping activity of various MICU1 mutants. Rescue was performed with wild type 
MICU1 (MICU1-HA) or MICU1-∆DID in the MICU1-KO cells. While MICU1-HA 
restored the low resting [Ca2+]m, MICU1-∆DID failed to lower it (Figure 2C,D). As a 
simple measure of the Ca2+-induced highly cooperative activation of MCU, in a single-
addition protocol, the initial response to 20Ca (difference between the [Ca2+]m 30s 
post-20Ca addition and the resting [Ca2+]m) was used. MICU1-∆DID expression decreased 
∆[Ca2+]m as in MICU1-KO MEFs (with empty vector), compared to WT MEFs (Figures 
2C,E). Thus, our data supports that mutation of the complementing sequence with MCU 
DIME motif interferes with MICU1 binding to and control of the Ca2+ fluxes of MCU.
Role of DID and the other motifs of MICU1 in intracellular Ca2+ homeostasis and cell 
survival
MICU1 is thus engaged in at least 3 interactions with components of the MCU complex: the 
previously documented dimerization with MICU2/MICU1, an interaction with EMRE, and 
our newly demonstrated interaction with MCU via the DID. To evaluate the MCU complex 
regulation by the interactions of MICU1 with MICU2, EMRE and MCU respectively, we 
interfered with each separately or in combination and performed simultaneous [Ca2+]c and 
[Ca2+]m measurements during store-operated Ca2+ entry (SOCE) in intact WT and MICU1-
KO HEKs. We opted for SOCE as the Ca2+ source because it stimulates mitochondrial Ca2+ 
uptake mostly via the global [Ca2+]c increase that we measured, so we could plot [Ca2+]m 
both as a function of time and [Ca2+]c. We generated three additional HA-tagged mutants of 
MICU1: the MICU1-∆dimer (C465A), which is incompetent for dimerization, MICU1-
∆EMRE (99KKKKR>99AAAAA) that lacks the EMRE-binding motif and a combination of 
MICU1-∆DID+∆EMRE+∆dimer. Co-transfection of MICU1-KO cells with MICU1 mutants 
and the mitochondrial matrix targeted Ca2+ indicator, mtCepia, allowed us to evaluate in 
each single cell [Ca2+]m and [Ca2+]c by fura2 (Figures 3A-B). The SOCE-mediated [Ca2+]m 
increase appeared earlier in MICU1-KO HEK cells rescued by either the empty vector, the 
MICU1-∆DID or the MICU1-∆DID+∆EMRE+∆dimer mutant, compared to WT HEKs or 
MICU1-KO cells rescued by the other MICU1 mutants (Figure 3B). The [Ca2+]m response 
60s post-Ca2+ addition revealed that both MICU1-∆DID and MICU1-∆DID+∆EMRE
+∆dimer mutant rescues took up Ca2+ similarly to the MICU1-KO cells while the MICU1-
∆EMRE and MICU1-∆dimer rescued cells took up initially less Ca2+ like the WT MICU1 
rescue (Figure 3C). Plotting [Ca2+]m against [Ca2+]c further supported that MICU1-KO cells 
rescued either by the empty vector or the MICU1-∆DID or the MICU1-∆DID+∆EMRE
+∆dimer mutant, showed a significant [Ca2+]m increase at lower [Ca2+]c than WT cells or 
the ones rescued by WT MICU1 and the other MICU1 mutants in MICU1-KO HEKs 
(Figure 3D). Indeed, to reach a similar level of [Ca2+]m (arbitrarily set at 1.2 ratio units), 
around 0.2µM of [Ca2+]c was sufficient in MICU1-KO and the MICU1-∆DID or MICU1-
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∆DID+∆EMRE+∆dimer rescues, whereas WT HEKs and MICU1-KO cells rescued by WT 
MICU1, MICU1-∆EMRE or MICU1-∆dimer constructs required a significantly higher 
[Ca2+]c (Figure 3E). We further assessed if the MICU1-∆DID mutant operated as a 
dominant-negative MCU complex component in these intact cells experiments. Similarly to 
MICU1-KO HEKs, co-expression of WT MICU1 and MICU1-∆DID led to a significant 
[Ca2+]m increase at lower [Ca2+]c than MICU1-KO HEKs rescued by WT MICU1 itself or 
along with a point mutant in EF1 of MICU1 (MICU1-EF1-D9E), thus unraveling a 
dominant-negative effect of MICU1-∆DID over WT MICU1 (Figures S3A-B). MICU1-EF1-
D9E was created to cause a specific perturbation in D239 of the EF hand but it was found to 
unalter the resting [Ca2+]m or the rescue of cooperativity and Ca2+ dependent activation of 
MCU complex (Figures S3C-E). Therefore, we used this construct as an alternative example 
of full rescue. Together, these data suggest that the MICU1-MCU interaction through the 
MICU1’s DID and MCU’s DIME motif is the most critical for the gatekeeping of the MCU 
complex.
Because the gatekeeping of MCU complex by MICU1 is central to avoiding mitochondrial 
Ca2+ overload, oxidative stress and cell death (Antony et al., 2016; Csordas et al., 2013; Liu 
et al., 2016; Mallilankaraman et al., 2012), we then proceeded to study the so-called delayed 
Ca2+ dysregulation by following the [Ca2+]c in intact HEKs subjected to prolonged Ca2+ 
entry (Figure 3F). After the initial [Ca2+]c rise a large delayed increase was observed only in 
mock- and MICU1-∆DID-rescued cells, whereas [Ca2+]c was maintained at a low level in 
MICU1-KO HEKs rescued by WT MICU1 or with the MICU1-EF1-D9E (Figure 3G).
The mitochondrial oxidative stress generated during prolonged SOCE conditions was 
measured using mtGrx1-RoGFP2, the fluorescence of which shows the ratio of oxidized and 
reduced glutathione (GSSG/GSH) and is unaffected by pH (Gutscher et al., 2008). The 
oxidative stress recorded in mock rescued cells was duplicated in the cells rescued by the 
MICU1-∆DID mutant, whereas oxidative stress was avoided in the cells rescued with WT 
MICU1 or MICU1-EF1-D9E constructs (Figure 3H). Importantly, all the MICU1 constructs 
were effectively expressed in the MICU1-KO cells, with no difference between the MICU1-
∆DID and MICU1-EF1-D9E mutants (Figure S4A). To conclude, these results indicate that 
MICU1 interaction with the D-ring of the DIME domain of MCU is required for 
gatekeeping of the MCU complex and in turn for cell survival.
DID mutant fails to rescue RuRed sensitivity
Finally, we investigated how RuRed sensitivity will be altered with expression of DID 
mutant of MICU1. While in WT and in MICU1-KO HEKs rescued by WT MICU1, or 
MICU1-EF1-D9E constructs, 30nM RuRed elicited a partial inhibition of the mitochondrial 
Ca2+ uptake rate, MICU1-KO HEKs rescued with empty vector or MICU1-∆DID displayed 
an almost complete inhibition of mitochondrial Ca2+ uptake, which could be only attained 
with 3µM RuRed in WT HEKs (Figure 4A-B). Indeed, a significantly higher inhibition of 
mitochondrial Ca2+ uptake by 30nM RuRed was obtained in MICU1-KO HEKs rescued 
with empty vector or MICU1-∆DID compared to either WT MICU1 or MICU1-EF1-D9E 
rescue (Figure 4B). Importantly, rescuing MICU1-KO HEKs by the MICU1-∆DID or 
MICU1-EF1-D9E constructs both lead to a higher MICU1 protein expression than that in 
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the WT HEK cells (Figure S4B). Because no release of any of the MICU1 constructs was 
noticed upon selective permeabilization of the plasma membrane and in the 
immunofluorescence experiments the expressed MICU1 constructs co-localized with the 
mitochondria (Figure S4C), they seem to be correctly targeted to the mitochondria. To test 
the localization to the IMS and proper interaction with EMRE for both MICU1-HA and 
MICU1-ΔDID-HA, we performed for the revision an immunoprecipitation experiment. 
Figure S4D shows that EMRE (tagged with Myc) pulled-down a comparable amount of WT 
MICU1 and MICU1-∆DID mutant (tagged with HA), thus confirming the proper 
localization of the MICU1-∆DID construct in the IMS and also that alteration of the 
MICU1-MCU interaction does not interfere with the MICU1-EMRE binding. Furthermore, 
the dominant negative effect of MICU1-ΔDID (Figure S3AB), also provides a functional 
evidence for the correct localization of MICU1-ΔDID. Thus, the failure of the DID mutant 
to restore the lower RuRed sensitivity confirms that the interaction between the DID of 
MICU1 and MCU, likely through its DIME domain, controls the Ca2+ flux and the RuRed 
sensitivity of the MCU complex.
DISCUSSION
The main finding of this study is that MICU1 interacts with the DIME motif of MCU and 
this interaction is required for both keeping MCU complex’s pore closed at low [Ca2+]c and 
optimally activated at high [Ca2+]c. Furthermore, this interaction also controls the MCU 
complex’s accessibility for its most characterized inhibitors. Thus, our findings are central to 
understanding the mechanisms that allow MICU1 to support cell survival by preventing 
mitochondrial Ca2+ overload and cause human disease in MICU1 deficiency, and provide 
important clues for mitochondrial drug development.
It has been broadly recognized that the Ca2+-sensing MICU1 is required for the control of 
MCU complex activity. As to the underlying mechanism, MICU1’s interactions with some 
components of the MCU complex have been dissected recently: disulfide bonds between the 
cysteines of MICU1 and MICU2 to form dimers (Patron et al., 2014; Petrungaro et al., 2015) 
and electrostatic interaction between the polyaspartate tail of EMRE and the polybasic 
sequence of MICU1 (Tsai et al., 2016). While Hoffman et al. had suggested a potential 
interaction between the N-terminal polybasic domain of MICU1 and the two interacting 
coiled-coil domains of MCU (Hoffman et al., 2013), this was later demonstrated to be 
indirect and mediated through EMRE (Tsai et al., 2016). MICU1’s interaction with MCU 
without EMRE was also indicated (Kovacs-Bogdan et al., 2014; Tsai et al., 2016) but until 
now, no direct interaction sites between MCU and MICU1 have been established. Given the 
involvement of the MCU complex and specifically, MICU1 in cell death and in diseases (Liu 
et al., 2017; Mammucari et al., 2017), a better understanding of the MICU1 interactions in 
the MCU complex was clearly needed.
We here reported a structural and functional interaction between the DID of MICU1 and the 
region identified as the selectivity filter domain of MCU, which controls the Ca2+ flux and 
the RuRed sensitivity of the MCU complex. Using sequence alignment, we identified a 
putative DIME interacting domain, DID, in the C-terminus of MICU1, engaging R440 and 
R443 in potential salt bridges with the D-ring of MCU. Decreased co-immunoprecipitation 
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between MCU and a MICU1 mutant of these two arginines (MICU1-∆DID: 
440KQRLMR445>440AQALMA445) supported a structural role for the DID in MICU1-
MCU interaction. Using Ca2+ imaging approaches in genetically rescued MICU1-KO MEFs 
and HEKs cells, we showed that the DID in MICU1 is required for both the threshold and 
cooperative activation of the MCU complex-mediated Ca2+ uptake. Furthermore, the DID 
was required to avoid mitochondrial Ca2+ overload, ROS dysregulation and the ensuing cell 
injury. Additionally, unlike MICU1, MICU1-∆DID expression in MICU1-KO HEKs did not 
decrease the RuRed sensitivity. Based on the proposed in vitro architecture of MCU as a 
pentamer (Oxenoid et al., 2016) and on our identification of the MICU1 DID interaction site 
with MCU, we here propose an updated model of the interactions of MICU1 within the 
MCU complex (Figure 4C): the two arginines R440 and R443 from one MICU1 would 
interact with the exposed D-ring (D261) of two MCU units from the pentamer to assure the 
physiological gatekeeping of the pore. In such a model, however it would be predicted that 
only one MICU1 dimer is required to block a pentameric MCU complex. Nevertheless, the 
pentameric assembly was established in vitro using C. elegans MCU that lacked the N-
terminal 165 amino acids (Oxenoid et al., 2016) and the in vivo MCU stoichiometry is yet to 
be determined. Some earlier studies, based on biochemical data, proposed tetrameric 
stoichiometry (Raffaello et al., 2013), in which case our model would be compatible with a 
pair of DID domains (in 2 MICU1 dimers) being able to fully engage with the D-ring of the 
MCU selectivity filter. Thus, elucidation of the in vivo architecture of MCU will be crucial 
to better appreciate the stoichiometry between MICU1 and MCU per MCU complex.
As to the relevance of the interactions with the different MCU complex components, our 
results identify the MICU1 interaction with MCU via its DID to be critical for the 
gatekeeping. In our experiments, relevance of EMRE and dimer formation is also confirmed 
but the MICU1-EMRE interaction rather appears as an additional stabilizing interaction to 
support the tight regulation of MCU by MICU1, which also fits with the only partial loss of 
threshold observed by Tsai et al. when disrupting the MICU1-EMRE interaction (Tsai et al., 
2016). Notably, direct control of MCU by MICU1 as an evolutionary conserved critical 
factor in gatekeeping is supported by the finding that the functional MCU complex of 
Dictyostelium discoideum consists of only MCU and one MICU isoform (Kovacs-Bogdan et 
al., 2014).
Our alignment of MICUs suggests that the DID, comprising of the two arginines, is 
conserved among the three MICUs. However, MICU2 fails to act as a gatekeeper in the 
absence of MICU1 (Kamer and Mootha, 2014). Because some interactions remained 
between MICU1-∆DID and MCU (Figure 2B) we speculate those interactions might be 
different for MICU1 and MICU2. Thus, further studies will be required to test whether the 
DID of MICU2 (or MICU3) can support an interaction with MCU.
One of the most unexpected finding of this work was that removal of MICU1 greatly 
sensitized mitochondria towards RuRed/Ru360 and this seems to be because of the DID 
limiting access of RuRed to its target site in the DIME of MCU. In the light of recent 
demonstration of tissue-specific differences in the MICU1 abundance relative to MCU 
(Paillard et al., 2017), the present finding might predict different RuRed/Ru360 sensitivity of 
MCU complex in various tissues, such as the particularly high sensitivity in the little 
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MICU1-containing cardiac muscle (Matlib et al., 1998). Furthermore, pharmacological 
targeting of the MCU complex by new and potentially therapeutically useful molecules has 
become an area of concerted research efforts (Arduino et al., 2017; D and Perocchi, 2018). 
Our findings might aid drug design and call attention to possible organ-specific differences 
in the sensitivity to future drugs sharing the target of RuRed/Ru360.
STAR METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Gyorgy Hajnoczky (gyorgy.hajnoczky@jefferson.edu).
EXPERIMENTAL MODEL AND DETAILS
Cell lines—Mouse embryonic fibroblasts (MEFs) were isolated by trypsin digestion from 
e14.5 embryos, using MICU1KO/loxP mice (for generation see (Antony et al., 2016)), and 
then immortalized. MEFs were cultured in DMEM (ATCC 30-2002) supplemented with 
penicillin, streptomycin at 37°C/5%O 2. MICU1-KO, and EMRE-KO HEK cells were 
kindly provided by Dr Vamsi Mootha and grown as previously described (Sancak et al., 
2013) and the stable MCU-Flag HEK by Dr Shey-Shing Sheu. Co-transfection of the control 
plasmid (pcDNA3-dest40) or the HA-tagged MICU1 constructs with the mitochondrial Ca2+ 
sensor mtCepia or the redox sensor mtGrx1-RoGFP2, was performed in MEFs and HEKs 
using Lipofectamine 3000 according to manufacturers’ protocol. Co-transection efficiency 
was confirmed by immunofluorescence via the HA tag (data not shown). Since a 4-fold 
higher expression was observed for the WT MICU1-HA construct compared to the other 
MICU1-HA mutants, we used ¼ of the DNA amount for the WT MICU1-HA plasmid.
Primary mouse hepatocytes—Primary hepatocytes were isolated by in situ retrograde 
perfusion with collagenase as previously described (Csordas et al., 2013), from 
MICU1loxP/loxP male mice 3 weeks after tail vein-injection with an AAV8-TBG-Cre or an 
AAV8-TBG-Null (1.3×1011 pfu/mouse) (Penn Vector Core). Only preparations with greater 
than 90% viability were used for subsequent experiments.
METHOD DETAILS
Measurements of mitochondrial Ca2+ uptake and membrane potential—
Saponin-permeabilized hepatocytes (2 millions), MEFs or HEKs (2.4 mg) were resuspended 
in 1.5 mL of intracellular medium (ICM) containing 120 mM KCl, 10 mM NaCl, 1 mM 
KH2PO4, 20 mM Tris-HEPES at pH 7.2, and supplemented with proteases inhibitors 
(leupeptin, antipain, pepstatin, 1mg/ml each), 2 mM MgATP, 2 μM thapsigargin and 
maintained in a stirred thermostated cuvette at 35°C. Assays were performed in presence of 
20 μM CGP-37157 and 1 mM succinate using a multiwavelength-excitation dual-
wavelength-emission fluorimeter (DeltaRAM, PTI). The extramitochondrial Ca2+ 
concentration [Ca2+]c was assessed using the ratiometric Ca2+ probe Fura2-FA (1.5 μM, 
Teflabs) or Fura-loAff (formerly Fura-FF) (1 μM, Teflabs). ∆ψm was measured with 1.5 μM 
TMRM (Invitrogen). Fura and TMRM fluorescence were recorded simultaneously using 
340-380 nm excitation and 500 nm emission, and 545 nm excitation and 580 nm emission, 
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respectively. Complete depolarization (maximum de-quench of TMRM fluorescence) was 
elicited using of the protonophore FCCP (2 μM). Calibration of the Fura signal was carried 
out at the end of each measurement, adding 1 mM CaCl2, followed by 10 mM EGTA/Tris, 
pH 8.5.
Construction of the HA-tagged MICU1 mutants—MICU1-EF1-D9E and MICU1-
∆EMRE were generated by site-directed mutagenesis in the cDNA sequence pcDNA-
DEST40 containing the wild type human MICU1 (provided by Vamsi K. Mootha). MICU1-
∆DID was created by inserting the synthetized sequence coding the appropriate mutations 
(Blue Heron) between the HindII/EcoNI restriction sites. Finally, the sequence resulting the 
C-terminal HA tag was inserted into each construct between the EcoNI/AgeI restriction 
sites. All constructs have been sequenced.
Co-immunoprecipitation—For co-IP experiments, HEK293 cells were grown in 10cm 
plates. After 48h post-transfection the plates were lysed in 1ml of a buffer containing 
120mM NaCl, 50mM MOPS (pH 7.2), 0.5mM EGTA, 1% 3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate (CHAPS) and protease 
inhibitor cocktail. Two equal aliquots (approximately 0.5mg protein) were 
immunoprecipitated with either 15μl FLAG-Ab beads or 1μg of HA or Myc antibody with 
50μl of Protein A sepharose (50% slurry).
Live cell Ca2+ imaging—First, the cells were pre-incubated in a serum-free extracellular 
medium (ECM, 120 mM NaCl, 5 mM NaHCO3, 10 mM Na-HEPES, 4.7 mM KCl, 1.2 mM 
KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, 10 mM glucose, pH7.4) containing 2% BSA. For 
SOCE experiments, ER stores were depleted by 10 min pretreatment with 2 μM 
thapsigarginin in Ca2+-free ECM. For permeabilized cells imaging, mitochondrial loading 
with 4μM Fura-FF AM was performed for 1h at 37°C, in in a serum-free extracellular 
medium (ECM, 120 mM NaCl, 5 mM NaHCO3, 10 mM Na-HEPES, 4.7 mM KCl, 1.2 mM 
KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, 10 Mm glucose, pH7.4) containing 2% BSA and 
0.012% Pluronic Acid. After plasma membrane permeabilization for 5 min at 37°C with 
40μg/ml sap onin, cells were washed once with ICM and then incubated with ICM 
supplemented with 2 mM MgATP, 2 μM thapsigargin, 2 mM Succinate, 20μM CGP-37157 
and 1μM Rhod2-FA. Fluorescence wide field imaging of [Ca2+]c and [Ca2+]m was carried 
out using a ProEMICU1024 EM-CCD (Princeton Instruments), fitted to Leica DMI 6000B 
inverted epifluorescence microscopes as previously described (Paillard et al., 2017).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are expressed as mean ± SEM. Experiments were performed at least 3 times, in 
duplicates or more. Statistical analysis was performed using ANOVA-1 followed by a 
Dunn’s post-hoc test for comparisons between multiple groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• MICU1 controls the RuRed/Ru360 sensitivity of the MCU complex
• MICU1’s R440/443 supports a direct interaction with MCU
• MICU1 R440/443-dependently competes with RuRed for interacting the D-
ring of MCU
• MICU1-MCU interaction is central for MCU gatekeeping and cell survival
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Figure 1: MICU1 controls the RuRedRu360 sensitivity of MCU complex
A-B) Time courses of the mitochondrial clearance of the [Ca2+]c rise upon addition of a 50 
μM CaCl2 bolus (50Ca) in permeabilized Ctrl (A) and MICU1-KD hepatocytes (B), with 
and without 100nM RuRed. Dashed line indicates complete inhibition of the mitochondrial 
Ca2+ uptake.
C)[RuRed] dose response for the percentage of inhibition of the initial mitochondrial uptake 
rate for a 50Ca bolus in Ctrl (black) and MICU1-KD (red) hepatocytes. A sigmoidal fit is 
displayed for each.
D) Percentage of uptake rate inhibition by 30nM Ru360 in Ctrl (black) and MICU1-KD 
(red) hepatocytes.
E-F) [RuRed] dose response for the percentage of uptake rate inhibition for a 20Ca bolus in 
MICU1+/+ and MICU1−/− MEFs (E) and HEKs (F). A sigmoidal fit is displayed for each.
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Mean ± SEM, n=3-4, * p<0.05 vs Ctrl, t-test.
See also Figure S1.
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Figure 2: Mutation of the complementing sequence interferes with MICU1 binding to and 
control of MCU
A) Alignment of MICU1, 2 and 3 showing previously identified sites in MICU1 involved in 
interactions with EMRE and MICU1/2, and proposing a potential MCU binding domain.
B) Upper: Representative immunoblotting of co-IP between MCU-FLAG and HA-tagged 
WT MICU1 or MICU1-∆DID mutant expressed in MCU-FLAG HEKs. Arrow indicates 
specific MICU1-HA band while asterisk is an unspecific band. Lower: Quantification of the 
relative MICU1 amount pulled down by MCU-FLAG in HEK cells expressing WT MICU1 
or MICU1-∆DID. Mean ± SEM, n=3, * p<0.05 vs WT, t-test.
C) [Ca2+]m measurements in permeabilized WT MEFs and MICU1-KO MEFs expressing 
empty vector, MICU1 or MICU1-∆DID and challenged with a bolus of 20μM CaCl2.
D) Quantification of resting [Ca2+]m as an index of thresholding of the MCU complex.
E) Calculations of the difference (∆[Ca2+]m) between the [Ca2+]m 30s post-20Ca addition 
and the resting [Ca2+]m as an index of cooperativity of the MCU complex.
Mean ± SEM, n=6, * p<0.05 vs WT, one-way ANOVA.
See also Figure S2.
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Figure 3: Critical role of the DID of MICU1 in Ca2+ homeostasis and cell survival.
A-B) SOCE-induced [Ca2+]c (A: Fura2 after calibration in μM) and [Ca2+]m (B: mt-Cepia) 
time courses in WT and MICU1-KO HEKs expressing the indicated MICU1 constructs, 
after addition of 3mM CaCl2..
C) Bar graph shows [Ca2+]m response at 60s, normalized to MICU1-KO HEKs response, 
from data in (B).
D) [Ca2+]m plotted against [Ca2+]c in individual cells.
E) Measurements of [Ca2+]c required to reach 1.2 [Ca2+]m on data from (D). Mean ± SEM, 
n=4-7, * p<0.05 vs WT, one-way ANOVA.).
F) Representative traces of [Ca2+]c measured by fura-ff-AM in intact HEKs cells after an 
addition of 10mM CaCl2 and in presence of 100μM H2O2.).
G) Quantification of the increase in [Ca2+]c from data in (F) (50min-10min).).
H) Quantification of the mitochondrial GSSG/GSH ratio using the mtGrx1-RoGFP2 sensor 
in the same conditions as in (F).
Mean ± SEM, n=3 independent experiments, * p<0.05 vs MICU1-KO, one-way ANOVA.
See also Figure S3 and S4.
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Figure 4: MICU1-MCU interaction through the DID of MICU1 is required to maintain RuRed 
sensitivity.
A) Time courses of the mitochondrial clearance of the [Ca2+]c rise upon addition of a 10 μM 
CaCl2 bolus (10Ca) in permeabilized WT and MICU1-KO HEKs with different MICU1 
constructs, with or without RuRed (3μM or 30nM).).
B) Bar graph shows percentage of uptake rate inhibition by 30nM RuRed in data from (A). 
Mean ± SEM, n=3, * p<0.05 vs WT, † p<0.05 vs MICU1-EF1-D9E, one-way ANOVA.).
C) Proposed model for MICU1 interaction with the MCU complex. In addition to the 
previously identified sites of MICU1 interaction with MICU1/2 through a disulfide bridge 
and with EMRE via electrostatic binding, we have identified a new functional domain in 
MICU1, the DID, for interaction with the DIME domain of MCU. More precisely, the two 
arginines 440 and 443 in MICU1 would interact via salt bridges with the accessible D-ring 
of the filter selectivity domain of MCU, to control the Ca2+ flux and RuRed sensitivity of the 
MCU complex.).
See also Figure S4.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit anti-MICU1 Sigma-Aldrich HPA037480
Rabbit anti-MCU Sigma-Aldrich HPA016480
Rabbit anti-MICU2 Abcam ab101465
Mouse anti-mtHsp70 Thermo Fisher MA3-028
Rabbit anti-prohibitin Abcam ab28172
Anti-HA polyclonal Invitrogen 71-5500
Anti-FLAG M2 Sigma-Aldrich F1804
Anti-Myc monoclonal Precision AG10004
Chemicals, Peptides, and Recombinant Proteins
Anti-DYKDDDDK (FLAG) beads Genscript A00187-200
Ruthenium Red Sigma R2751
Fura-2 (AM) Teflabs 0-103
Fura-2 (salt) Teflabs 0-104
Fura-2 low affinity (AM) Teflabs 0-136
Fura-2 low affinity (salt) Teflabs 0-137
Thapsigargin Enzo Life Sciences BML-PE180-0005
CGP-37157 Enzo Life Sciences BML-CM119-0005
Lipofectamine 3000 Life Technologies L3000008
Complete protease inhibitor cocktail (EDTA free) Roche 11873580001
Protein A Sepharose Abcam ab193256
Critical Commercial Assays
DC Protein Assay Biorad 5000112
Experimental Models: Cell Lines
MICU1loxp/loxp MEF Antony et al., 2016 N/A
MICU1KO/KO MEF Antony et al., 2016 N/A
MICU1-KO HEK293T Sancak et al., 2013 N/A
EMRE-KO HEK293T Sancak et al., 2013 N/A
HEK293T stably overexpressing mouse MCU-FLAG O-Uchi et al., 2014 N/A
WT HEK293T Sancak et al., 2013 N/A
Recombinant DNA
pcDNA-dest40-MICU1-HA Kamer et al., 2017 N/A
pcDNA3.1-MICU1-C465A-HA Patron et al., 2014 N/A
pcDNA-dest40-M1-EF1-D9E-HA, M1-∆DID-HA and M1-∆EMRE-HA This paper N/A
EMRE-Myc This paper N/A
Mt-Cepia This paper N/A
mtGrx1-RoGFP This paper N/A
Software and Algorithms
Canvas X N/A N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
Endnote N/A N/A
SigmaPlot 12.5 N/A N/A
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